What Is EGFR Exon 20 Insertion Mutant NSCLC: 15% Of Lung Cancer In The United States, 50% Overall In Asian Countries

What Is EGFR Exon 20 Insertion Mutant NSCLC: 15% Of Lung Cancer In The United States, 50% Overall In Asian Countries

Annual-Meeting

1 year
77 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Joel Neal MD Of Stanford University Medical Center Discusses What Is EGFR Exon 20 Insertion Mutant NSCLC: 15% Of Lung Cancer In The United States, 50% Overall In Asian Countries.
Up Next Autoplay